Literature DB >> 25560058

Nocardia prosthetic knee infection successfully treated by one-stage exchange: case report and review.

F Laurent, H Rodriguez-Villalobos, O Cornu, B Vandercam, J C Yombi.   

Abstract

A 64-year-old man with a history of sarcoidosis on corticosteroids and azathioprine was admitted to our hospital with complaints of worsening left knee pain and swelling for the past 3 weeks. His past medical history is also significant for severe osteoarthritis requiring a cemented total left knee arthroplasty 1 year ago. Diagnostic investigation during his hospital admission eventually led to the diagnosis of Nocardia nova knee prosthetic joint infection in the setting of a disseminated nocardiosis. He was successful treated by one-stage complete hardware exchange in conjunction with an adapted antibiotic therapy regimen (meropenem and doxycycline followed by ceftriaxone and doxycycline). Two years later, his recovery was deemed excellent.

Entities:  

Keywords:  Immunodepression,; Knee,; Nocardia nova,; One-stage exchange; Prosthetic joint infection,; Sarcoidosis,

Mesh:

Year:  2015        PMID: 25560058     DOI: 10.1179/2295333714Y.0000000109

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  3 in total

1.  Post-traumatic endophthalmitis caused by Nocardia nova.

Authors:  Jesús Rodríguez-Lozano; Carlos Armiñanzas Castillo; Carlos Ruiz de Alegría Puig; Juan Antonio Ventosa Ayarza; Maria Carmen Fariñas; Jesús Agüero; Jorge Calvo
Journal:  JMM Case Rep       Date:  2019-02-20

2.  A Rare Case of Chest Wall Abscess by Nocardia in a Patient With Sarcoidosis.

Authors:  Mahreen Sana; Faheem Mahmood Butt; Muhammad Imran Ul Hasan; Adnan Amir
Journal:  Cureus       Date:  2022-07-12

Review 3.  Nocardia Arthritis: 3 Cases and Literature Review.

Authors:  Hélène Chaussade; David Lebeaux; Guillaume Gras; Emilie Catherinot; Blandine Rammaert; Sylvain Poiree; Hervé Lecuyer; Valérie Zeller; Louis Bernard; Olivier Lortholary
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.